Loading company…
Paean Biotechnology develops mitochondria-based therapies for rare diseases and cancer.
Paean Biotechnology develops mitochondrial therapies, including MitoTherapy and Mitoceuticals, for rare diseases and cancer. Founded in 2013 and based in Daejeon, South Korea, it raised KRW 4.5 billion in January 2021 from Hana Ventures and Korea Investment Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in